News
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical ...
Cashin, MD, chief medical officer, Novotech, shares insights on how sponsors and CROs can cultivate a “one team” mindset by setting the right leadership tone, encouraging collaboration, and leveraging ...
Brian Ongioni, chief product officer, uMotif, explains how early site feedback and patient involvement in software ...
Cashin, MD, chief medical officer, Novotech, shares why clear communication, strong leadership, and cultural alignment are essential to building effective partnerships between CROs, sponsors, and ...
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation ...
New Phase III data published in The New England Journal of Medicine show elinzanetant, a nonhormonal dual NK-1/NK-3 receptor antagonist, significantly reduced vasomotor symptoms, improved sleep, and ...
How Medical Writing and Regulatory Affairs Professionals Can Embrace and Deploy Generative AI at Scale ...
Peter Ronco, CEO, Emmes, explains how the company is investing in transparent goal setting, comprehensive education, and ...
Cashin, MD, chief operating officer, Novotech, explains why seamless collaboration between CROs and sponsors is critical to advancing clinical trials, and reflects on Novotech’s recognition as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results